Lupin: Focus On Inhalation & Biosimilars To Aid Margins In Medium-Term | Ideas For Profit

Описание: Possibility of positive developments on the product pipeline front and restructuring initiatives can accelerate earnings growth for Lupin. We continue to believe this opportunity is more suitable for investors with high risk appetite and those who are ready to hold it long enough for the product pipeline to unfold.

https://www.moneycontrol.com/news/bus...

Follow us:
Website: https://www.moneycontrol.com/
Facebook:   / moneycontrol  
Twitter:   / moneycontrolcom  
Instagram:   / moneycontrolcom  

#moneycontrol #Lupin #LupinQ4FY21